Commentary

Sodium vs Potassium for Lowering Blood Pressure?


 

No Salt War Here

Despite their different editorial takes, Dr. Hiremath and Dr. Juraschek largely agree on the broad strokes of the problem. This isn’t X (or Twitter) after all. Potassium supplementation may be useful in some parts of the world but may not address the underlying problem in countries where processed foods are the source of most dietary sodium.

The CARDIA-SSBP trial showed that a very low–sodium diet had the same blood pressure–lowering effect as a first-line antihypertensive, but most people will not be able to limit themselves to 500 mg of dietary sodium per day. In CARDIA-SSBP, just as in DASH, participants were provided with meals from study kitchens. They were not just told to eat less salt, which would almost certainly have failed.

“We should aim for stuff that is practical and doable rather than aim for stuff that cannot be done,” according to Dr. Hiremath. Whether that should be salt substitutes or policy change may depend on which part of the planet you live on.

One recent positive change may herald the beginning of a policy change, at least in the United States. In March 2023, the US Food and Drug Administration proposed a rule change to allow salt substitutes to be labeled as salt. This would make it easier for food manufacturers to swap out sodium chloride for a low-sodium alternative and reduce the amount of sodium in the US diet without having a large impact on taste and consumer uptake. Both Dr. Hiremath and Dr. Juraschek agree that it may not be enough on its own but that it’s a start.

Christopher Labos is a cardiologist with a degree in epidemiology. He spends most of his time doing things that he doesn’t get paid for, like research, teaching, and podcasting. Occasionally, he finds time to practice cardiology to pay the rent. He realizes that half of his research findings will be disproved in 5 years; he just doesn’t know which half. He is a regular contributor to the Montreal Gazette, CJAD radio, and CTV television in Montreal, and is host of the award-winning podcast The Body of Evidence.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Strategies for complete B-cell depletion evolve for patients with lupus nephritis
Federal Practitioner
Better than dialysis? Artificial kidney could be the future
Federal Practitioner
Medicare announces 10 drugs targeted for price cuts in 2026
Federal Practitioner
Dietary nitrates reduce contrast-induced nephropathy in ACS
Federal Practitioner
Low-dose methotrexate carries higher risk for older patients with CKD
Federal Practitioner
Chronic Kidney Disease and Military Service in US Adults, 1999-2018
Federal Practitioner
Meet the newest acronym in primary care: CKM
Federal Practitioner
Can a Healthy Gut Microbiome Prevent Kidney Stones?
Federal Practitioner
Hypocalcemia Risk Warning Added to Osteoporosis Drug
Federal Practitioner
High Salt Intake Linked to Increased Risk for Kidney Disease
Federal Practitioner